Article
ImmunoGen (IMGN) Q2 Earnings and Revenues Miss Estimates
Rating:
0.0
Views:
66
Likes:
1
Library:
1
ImmunoGen (IMGN) reports a wider-than-expected loss for second-quarter 2022. It also misses revenue estimates.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value